본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

The Journal of neuroscience : the official journal of the Society for Neuroscience v.37 no.4, 2017년, pp.1039 - 1054   SCI SCIE
본 등재정보는 저널의 등재정보를 참고하여 보여주는 베타서비스로 정확한 논문의 등재여부는 등재기관에 확인하시기 바랍니다.

Opposing Effects of Valproic Acid Treatment Mediated by Histone Deacetylase Inhibitor Activity in Four Transgenic X. laevis Models of Retinitis Pigmentosa

Vent-Schmidt, Ruanne Y.J. (Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada V5Z 3N9 ); Wen, Runxia H. (Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada V5Z 3N9 ); Zong, Zusheng (Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada V5Z 3N9 ); Chiu, Colette N. (Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada V5Z 3N9 ); Tam, Beatrice M. (Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada V5Z 3N9 ); May, Christopher G. (Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada V5Z 3N9 ); Moritz, Orson L. (Department of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, British Columbia, Canada V5Z 3N9 );
  • 초록  

    Retinitis pigmentosa (RP) is an inherited retinal degeneration (RD) that leads to blindness for which no treatment is available. RP is frequently caused by mutations in Rhodopsin ; in some animal models, RD is exacerbated by light. Valproic acid (VPA) is a proposed treatment for RP and other neurodegenerative disorders, with a phase II trial for RP under way. However, the therapeutic mechanism is unclear, with minimal research supporting its use in RP. We investigated the effects of VPA on Xenopus laevis models of RP expressing human P23H, T17M, T4K, and Q344ter rhodopsins, which are associated with RP in humans. VPA ameliorated RD associated with P23H rhodopsin and promoted clearing of mutant rhodopsin from photoreceptors. The effect was equal to that of dark rearing, with no additive effect observed. Rescue of visual function was confirmed by electroretinography. In contrast, VPA exacerbated RD caused by T17M rhodopsin in light, but had no effect in darkness. Effects in T4K and Q344ter rhodopsin models were also negative. These effects of VPA were paralleled by treatment with three additional histone deacetylase (HDAC) inhibitors, but not other antipsychotics, chemical chaperones, or VPA structural analogues. In WT retinas, VPA treatment increased histone H3 acetylation. In addition, electron microscopy showed increased autophagosomes in rod inner segments with HDAC inhibitor (HDACi) treatment, potentially linking the therapeutic effects in P23H rhodopsin animals and negative effects in other models with autophagy. Our results suggest that the success or failure of VPA treatment is dependent on genotype and that HDACi treatment is contraindicated for some RP cases. SIGNIFICANCE STATEMENT Retinitis pigmentosa (RP) is an inherited, degenerative retinal disease that leads to blindness for which no therapy is available. We determined that valproic acid (VPA), currently undergoing a phase II trial for RP, has both beneficial and detrimental effects in animal models of RP depending on the underlying disease mechanism and that both effects are due to histone deacetylase (HDAC) inhibition possibly linked to autophagy regulation. Off-label use of VPA and other HDAC inhibitors for the treatment of RP should be limited to the research setting until this effect is understood and can be predicted. Our study suggests that, unless genotype is accounted for, clinical trials for RP treatments may give negative results due to multiple disease mechanisms with differential responses to therapeutic interventions.


  • 주제어

    autophagy .   HDAC inhibitor .   retinal degeneration .   retinitis pigmentosa .   rhodopsin .   valproic acid.  

 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

유료다운로드
  • 원문이 없습니다.

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기